Clinical Trials Browser

Phase 1 × Active not recruiting × lonafarnib × Clear all

NCT00102648 2024-10-17

Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide

Phase 1 Active not recruiting

Glioblastoma, Supratentorial Neoplasms, Gliosarcoma